Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Active, Not Recruiting

Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

NCT06059547

Conditions
Adult Solid Tumor, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations
  • IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University Milan, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Oncologia Medica Roma, Italy
  • A.O.U. Città della Salute e della Scienza di Torino Torino, Italy
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

NCT03697850

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges Francois Leclerc Dijon, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Active, Not Recruiting

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

NCT03022825

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • UCLA Department of Urology Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 28 locations
View Trial Details

Related conditions